A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995)
Clinical trial NCT03985878 · TERMINATED
Trial details
- NCT number
- NCT03985878
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2022-08-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.